Fonte: Hepatology International. Unidade: FM
Assuntos: GENÓTIPOS, HEPATITE CRÔNICA, INTERFERONS, VÍRUS DA HEPATITE C
ABNT
SHIFFMAN, Mitchell L. et al. Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial. Hepatology International, v. 8, n. 4, p. 517-526, 2014Tradução . . Disponível em: https://doi.org/10.1007/s12072-014-9555-3. Acesso em: 19 nov. 2024.APA
Shiffman, M. L., Cheinquer, H., Berg, C. P., Berg, T., Figueiredo-Mendes, C. de, Dore, G. J., et al. (2014). Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial. Hepatology International, 8( 4), 517-526. doi:10.1007/s12072-014-9555-3NLM
Shiffman ML, Cheinquer H, Berg CP, Berg T, Figueiredo-Mendes C de, Dore GJ, Ferraz ML, Mendes-Correa MC, Lima MP, Parise ER, Rios AMP, Reuter T, Sanyal AJ, Shafran SD, Hohmann M, Tatsch F, Bakalos G, Zeuzem S. Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial [Internet]. Hepatology International. 2014 ; 8( 4): 517-526.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1007/s12072-014-9555-3Vancouver
Shiffman ML, Cheinquer H, Berg CP, Berg T, Figueiredo-Mendes C de, Dore GJ, Ferraz ML, Mendes-Correa MC, Lima MP, Parise ER, Rios AMP, Reuter T, Sanyal AJ, Shafran SD, Hohmann M, Tatsch F, Bakalos G, Zeuzem S. Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial [Internet]. Hepatology International. 2014 ; 8( 4): 517-526.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1007/s12072-014-9555-3